167 related articles for article (PubMed ID: 23752507)
1. Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model.
Moss JA; Malone AM; Smith TJ; Kennedy S; Nguyen C; Vincent KL; Motamedi M; Baum MM
Antimicrob Agents Chemother; 2013 Aug; 57(8):3994-7. PubMed ID: 23752507
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.
Moss JA; Malone AM; Smith TJ; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Vincent KL; Motamedi M; Friend DR; Clark MR; Baum MM
Antimicrob Agents Chemother; 2012 Feb; 56(2):875-82. PubMed ID: 22123689
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.
Moss JA; Srinivasan P; Smith TJ; Butkyavichene I; Lopez G; Brooks AA; Martin A; Dinh CT; Smith JM; Baum MM
Antimicrob Agents Chemother; 2014 Sep; 58(9):5125-35. PubMed ID: 24936594
[TBL] [Abstract][Full Text] [Related]
4. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
Smith JM; Moss JA; Srinivasan P; Butkyavichene I; Gunawardana M; Fanter R; Miller CS; Sanchez D; Yang F; Ellis S; Zhang J; Marzinke MA; Hendrix CW; Kapoor A; Baum MM
PLoS One; 2017; 12(10):e0185946. PubMed ID: 28982161
[TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.
Moss JA; Malone AM; Smith TJ; Butkyavichene I; Cortez C; Gilman J; Kennedy S; Kopin E; Nguyen C; Sinha P; Hendry RM; Guenthner P; Holder A; Martin A; McNicholl J; Mitchell J; Pau CP; Srinivasan P; Smith JM; Baum MM
Antimicrob Agents Chemother; 2012 Nov; 56(11):5952-60. PubMed ID: 22964245
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings.
Moss JA; Baum MM; Malone AM; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Willis RA; Vincent KL; Motamedi M; Smith TJ
AIDS; 2012 Mar; 26(6):707-10. PubMed ID: 22210639
[TBL] [Abstract][Full Text] [Related]
7. Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.
Moss JA; Butkyavichene I; Churchman SA; Gunawardana M; Fanter R; Miller CS; Yang F; Easley JT; Marzinke MA; Hendrix CW; Smith TJ; Baum MM
Antimicrob Agents Chemother; 2016 Jun; 60(6):3759-66. PubMed ID: 27067321
[TBL] [Abstract][Full Text] [Related]
8. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.
Johnson TJ; Clark MR; Albright TH; Nebeker JS; Tuitupou AL; Clark JT; Fabian J; McCabe RT; Chandra N; Doncel GF; Friend DR; Kiser PF
Antimicrob Agents Chemother; 2012 Dec; 56(12):6272-83. PubMed ID: 23006751
[TBL] [Abstract][Full Text] [Related]
9. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812
[TBL] [Abstract][Full Text] [Related]
10. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
[TBL] [Abstract][Full Text] [Related]
11. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir.
Johnson TJ; Gupta KM; Fabian J; Albright TH; Kiser PF
Eur J Pharm Sci; 2010 Feb; 39(4):203-12. PubMed ID: 19958831
[TBL] [Abstract][Full Text] [Related]
12. An intravaginal ring for the simultaneous delivery of multiple drugs.
Baum MM; Butkyavichene I; Gilman J; Kennedy S; Kopin E; Malone AM; Nguyen C; Smith TJ; Friend DR; Clark MR; Moss JA
J Pharm Sci; 2012 Aug; 101(8):2833-43. PubMed ID: 22619076
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
Friend DR
Expert Opin Drug Deliv; 2012 Apr; 9(4):417-27. PubMed ID: 22385316
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of tenofovir disoproxil fumarate released from an intravaginal ring in pigtailed macaques after 6 months of continuous use.
Srinivasan P; Dinh C; Zhang J; Pau CP; McNicholl JM; Lo Y; Herold BC; Teller R; Kiser P; Smith JM
J Med Primatol; 2014 Oct; 43(5):364-9. PubMed ID: 25379594
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tolerability of Tenofovir disoproxil fumarate 300 mg once daily: an open-label, single- and multiple-dose study in healthy Chinese subjects.
Hu CY; Liu YM; Liu Y; Chen Q; Wang W; Wu K; Dong J; Li J; Jia JY; Lu C; Sun SX; Yu C; Li X
Clin Ther; 2013 Dec; 35(12):1884-9. PubMed ID: 24148552
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.
Dumond JB; Yeh RF; Patterson KB; Corbett AH; Jung BH; Rezk NL; Bridges AS; Stewart PW; Cohen MS; Kashuba AD
AIDS; 2007 Sep; 21(14):1899-907. PubMed ID: 17721097
[TBL] [Abstract][Full Text] [Related]
17. An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.
Baum MM; Butkyavichene I; Churchman SA; Lopez G; Miller CS; Smith TJ; Moss JA
Int J Pharm; 2015 Nov; 495(1):579-587. PubMed ID: 26386138
[TBL] [Abstract][Full Text] [Related]
18. Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapine.
Amoroso A; Gilliam BL; Talwani R; Boyce C; Redfield RR; Davis CE
HIV Clin Trials; 2009; 10(5):320-3. PubMed ID: 19906624
[TBL] [Abstract][Full Text] [Related]
19. Vaginal ring contraception.
Kerns J; Darney P
Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
[TBL] [Abstract][Full Text] [Related]
20. Microbial biofilms on the surface of intravaginal rings worn in non-human primates.
Gunawardana M; Moss JA; Smith TJ; Kennedy S; Kopin E; Nguyen C; Malone AM; Rabe L; Schaudinn C; Webster P; Srinivasan P; Sweeney ED; Smith JM; Baum MM
J Med Microbiol; 2011 Jun; 60(Pt 6):828-837. PubMed ID: 21393449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
